Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) Tax Provisions (2019 - 2025)

Historic Tax Provisions for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to -$616000.0.

  • Legend Biotech's Tax Provisions rose 8611.05% to -$616000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year increase of 3571.56%. This contributed to the annual value of -$18893.0 for FY2024, which is 111357.3% down from last year.
  • Legend Biotech's Tax Provisions amounted to -$616000.0 in Q3 2025, which was up 8611.05% from -$582000.0 recorded in Q2 2025.
  • Over the past 5 years, Legend Biotech's Tax Provisions peaked at $288000.0 during Q3 2023, and registered a low of -$4.4 million during Q3 2024.
  • Its 5-year average for Tax Provisions is -$668175.1, with a median of -$155000.0 in 2022.
  • Per our database at Business Quant, Legend Biotech's Tax Provisions surged by 28947.37% in 2023 and then plummeted by 3562000.0% in 2025.
  • Quarter analysis of 5 years shows Legend Biotech's Tax Provisions stood at -$3.6 million in 2021, then skyrocketed by 95.77% to -$153000.0 in 2022, then surged by 101.3% to $1994.0 in 2023, then crashed by 813.49% to -$14227.0 in 2024, then plummeted by 4229.8% to -$616000.0 in 2025.
  • Its Tax Provisions stands at -$616000.0 for Q3 2025, versus -$582000.0 for Q2 2025 and -$1.8 million for Q1 2025.